SCHEMBL6161100

SCHEMBL6161100

CN(C)CCCN(C)C(=O)C(N)Cc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALPI P09923 1/20 0.51
PKM P14618 1/20 0.51
PTGS1 P23219 1/20 0.51
XIAP P98170 1/20 0.51
SLC7A5 Q01650 1/20 0.51
LTA4H P09960 1/20 0.47
HPGD P15428 1/20 0.47
MC4R P32245 4/20 0.46
MC5R P33032 3/20 0.46
MC3R P41968 3/20 0.46
UBE2N P61088 1/20 0.46
SLC15A1 P46059 1/20 0.45
CHRM1 P11229 1/20 0.45
HTT P42858 1/20 0.43
SIGMAR1 Q99720 1/20 0.42
SLC1A3 P43003 1/20 0.42
SLC1A2 P43004 1/20 0.42
SLC1A1 P43005 1/20 0.42
HDAC8 Q9BY41 1/20 0.41
NPY2R P49146 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7402964 0.86 SIGMAR1 (0.54) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL7397855 0.86 SIGMAR1 (0.54) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL17337673 0.85 HPGD (0.56) ALPIPKMPTGS1XIAPSLC7A5
Hydrochloric Acid SCHEMBL11271286 0.83 LTA4H (0.56) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL16254301 0.82 ANPEP (0.53) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL900941 0.81 HPGD (0.69) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL26518995 0.81 ALPI (0.58) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL2376130 0.81 SLC7A5 (0.50) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL2376135 0.81 SLC7A5 (0.50) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL11357126 0.80 ALPI (0.56) ALPIPKMPTGS1XIAPSLC7A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1134213-B1 Process for the preparation of substituted N-(indole-2-carbonyl)- glycinamides PFIZER (US) 2005-11-02 EP disclosed
EP-0832065-B1 SUBSTITUTED N-(INDOLE-2-CARBONYL)-GLYCINAMIDES AND DERIVATIVES AS GLYCOGEN PHOSPHORYLASE INHIBITORS PFIZER (US) 2001-10-10 EP disclosed
EP-1134213-A2 Process for the preparation of substituted N-(indole-2-carbonyl)- glycinamides PFIZER INC. (US) 2001-09-19 EP disclosed
US-6277877-B1 GLYCOGEN PHOSPHORYLASE INHIBITOR; ANTIDIABETIC AGENTS PFIZER, INC. 2001-08-21 US disclosed
US-6107329-A HYPOTENSIVE AGENTS; CARDIOVASCULAR DISORDERS PFIZER, INC. (US) 2000-08-22 US disclosed
WO-1996039384-A1 SUBSTITUTED N-(INDOLE-2-CARBONYL)-GLYCINAMIDES AND DERIVATIVES AS GLYCOGEN PHOSPHORYLASE INHIBITORS PFIZER, INC. (US) 1996-12-12 WO disclosed